adi powerlab and labchart system Search Results


flow head mlt 1000l  (POWERLAB INC)
90
POWERLAB INC flow head mlt 1000l
Flow Head Mlt 1000l, supplied by POWERLAB INC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/flow head mlt 1000l/product/POWERLAB INC
Average 90 stars, based on 1 article reviews
flow head mlt 1000l - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
powerlab® model ml870  (POWERLAB INC)
90
POWERLAB INC powerlab® model ml870
Powerlab® Model Ml870, supplied by POWERLAB INC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/powerlab® model ml870/product/POWERLAB INC
Average 90 stars, based on 1 article reviews
powerlab® model ml870 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
labchart  (ADInstruments)
98
ADInstruments labchart
Labchart, supplied by ADInstruments, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/labchart/product/ADInstruments
Average 98 stars, based on 1 article reviews
labchart - by Bioz Stars, 2026-05
98/100 stars
  Buy from Supplier
powerlab/labchart combination  (POWERLAB INC)
90
POWERLAB INC powerlab/labchart combination
Powerlab/Labchart Combination, supplied by POWERLAB INC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/powerlab/labchart combination/product/POWERLAB INC
Average 90 stars, based on 1 article reviews
powerlab/labchart combination - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
4/30 with labchart software  (POWERLAB INC)
90
POWERLAB INC 4/30 with labchart software
4/30 With Labchart Software, supplied by POWERLAB INC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/4/30 with labchart software/product/POWERLAB INC
Average 90 stars, based on 1 article reviews
4/30 with labchart software - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
powerlab/4sp  (POWERLAB INC)
90
POWERLAB INC powerlab/4sp
Powerlab/4sp, supplied by POWERLAB INC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/powerlab/4sp/product/POWERLAB INC
Average 90 stars, based on 1 article reviews
powerlab/4sp - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
pc-based data acquisition system labchart 8.0  (POWERLAB INC)
90
POWERLAB INC pc-based data acquisition system labchart 8.0
Pc Based Data Acquisition System Labchart 8.0, supplied by POWERLAB INC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pc-based data acquisition system labchart 8.0/product/POWERLAB INC
Average 90 stars, based on 1 article reviews
pc-based data acquisition system labchart 8.0 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
electrocardiogram ecg  (ADInstruments)
98
ADInstruments electrocardiogram ecg
Experiment 1: Brain norepinephrine infusion <t>ECG.</t> (a) Mortality during severe hypoglycemia was 16% in aCSF (white bar) and 35% in Nore (black bar) but this was not statistically different. (b) Third‐degree heart block was increased in Nore compared to aCSF. (c) ST elevation was increased in Nore whereas aCSF did not experience ST elevation. (d) Heart rate decreased in both groups during severe hypoglycemia (SH) compared to their respective basals ( p < 0.001). During severe hypoglycemia, Nore had a slight but significantly higher heart rate compared to aCSF ( p < 0.02). (e) QTc prolongation occurred in both groups during severe hypoglycemia compared to basal with no differences between the two groups ( p < 0.001). (f) Representative <t>ECG</t> from aCSF (left) and Nore (right). Basal: Both groups show normal sinus rhythm. T wave increase: Both groups had some rats that experienced this. ST elevation: This did not occur in aCSF. Instead normal sinus rhythm at similar timepoint during severe hypoglycemia is shown. Nore shows ST elevation. Third‐degree heart block: Rats from both groups experienced third‐degree heart block. Data are represented as box and whisker plots with median and interquaritle range and min to max values. N = 20–26/group.
Electrocardiogram Ecg, supplied by ADInstruments, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/electrocardiogram ecg/product/ADInstruments
Average 98 stars, based on 1 article reviews
electrocardiogram ecg - by Bioz Stars, 2026-05
98/100 stars
  Buy from Supplier
8/30  (POWERLAB INC)
90
POWERLAB INC 8/30
Experiment 1: Brain norepinephrine infusion <t>ECG.</t> (a) Mortality during severe hypoglycemia was 16% in aCSF (white bar) and 35% in Nore (black bar) but this was not statistically different. (b) Third‐degree heart block was increased in Nore compared to aCSF. (c) ST elevation was increased in Nore whereas aCSF did not experience ST elevation. (d) Heart rate decreased in both groups during severe hypoglycemia (SH) compared to their respective basals ( p < 0.001). During severe hypoglycemia, Nore had a slight but significantly higher heart rate compared to aCSF ( p < 0.02). (e) QTc prolongation occurred in both groups during severe hypoglycemia compared to basal with no differences between the two groups ( p < 0.001). (f) Representative <t>ECG</t> from aCSF (left) and Nore (right). Basal: Both groups show normal sinus rhythm. T wave increase: Both groups had some rats that experienced this. ST elevation: This did not occur in aCSF. Instead normal sinus rhythm at similar timepoint during severe hypoglycemia is shown. Nore shows ST elevation. Third‐degree heart block: Rats from both groups experienced third‐degree heart block. Data are represented as box and whisker plots with median and interquaritle range and min to max values. N = 20–26/group.
8/30, supplied by POWERLAB INC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/8/30/product/POWERLAB INC
Average 90 stars, based on 1 article reviews
8/30 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
labchart program  (POWERLAB INC)
90
POWERLAB INC labchart program
Experiment 1: Brain norepinephrine infusion <t>ECG.</t> (a) Mortality during severe hypoglycemia was 16% in aCSF (white bar) and 35% in Nore (black bar) but this was not statistically different. (b) Third‐degree heart block was increased in Nore compared to aCSF. (c) ST elevation was increased in Nore whereas aCSF did not experience ST elevation. (d) Heart rate decreased in both groups during severe hypoglycemia (SH) compared to their respective basals ( p < 0.001). During severe hypoglycemia, Nore had a slight but significantly higher heart rate compared to aCSF ( p < 0.02). (e) QTc prolongation occurred in both groups during severe hypoglycemia compared to basal with no differences between the two groups ( p < 0.001). (f) Representative <t>ECG</t> from aCSF (left) and Nore (right). Basal: Both groups show normal sinus rhythm. T wave increase: Both groups had some rats that experienced this. ST elevation: This did not occur in aCSF. Instead normal sinus rhythm at similar timepoint during severe hypoglycemia is shown. Nore shows ST elevation. Third‐degree heart block: Rats from both groups experienced third‐degree heart block. Data are represented as box and whisker plots with median and interquaritle range and min to max values. N = 20–26/group.
Labchart Program, supplied by POWERLAB INC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/labchart program/product/POWERLAB INC
Average 90 stars, based on 1 article reviews
labchart program - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
labchart software  (ADInstruments)
93
ADInstruments labchart software
Experiment 1: Brain norepinephrine infusion <t>ECG.</t> (a) Mortality during severe hypoglycemia was 16% in aCSF (white bar) and 35% in Nore (black bar) but this was not statistically different. (b) Third‐degree heart block was increased in Nore compared to aCSF. (c) ST elevation was increased in Nore whereas aCSF did not experience ST elevation. (d) Heart rate decreased in both groups during severe hypoglycemia (SH) compared to their respective basals ( p < 0.001). During severe hypoglycemia, Nore had a slight but significantly higher heart rate compared to aCSF ( p < 0.02). (e) QTc prolongation occurred in both groups during severe hypoglycemia compared to basal with no differences between the two groups ( p < 0.001). (f) Representative <t>ECG</t> from aCSF (left) and Nore (right). Basal: Both groups show normal sinus rhythm. T wave increase: Both groups had some rats that experienced this. ST elevation: This did not occur in aCSF. Instead normal sinus rhythm at similar timepoint during severe hypoglycemia is shown. Nore shows ST elevation. Third‐degree heart block: Rats from both groups experienced third‐degree heart block. Data are represented as box and whisker plots with median and interquaritle range and min to max values. N = 20–26/group.
Labchart Software, supplied by ADInstruments, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/labchart software/product/ADInstruments
Average 93 stars, based on 1 article reviews
labchart software - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier
hrv analysis software labchart pro version 8  (POWERLAB INC)
90
POWERLAB INC hrv analysis software labchart pro version 8
Experiment 1: Brain norepinephrine infusion <t>ECG.</t> (a) Mortality during severe hypoglycemia was 16% in aCSF (white bar) and 35% in Nore (black bar) but this was not statistically different. (b) Third‐degree heart block was increased in Nore compared to aCSF. (c) ST elevation was increased in Nore whereas aCSF did not experience ST elevation. (d) Heart rate decreased in both groups during severe hypoglycemia (SH) compared to their respective basals ( p < 0.001). During severe hypoglycemia, Nore had a slight but significantly higher heart rate compared to aCSF ( p < 0.02). (e) QTc prolongation occurred in both groups during severe hypoglycemia compared to basal with no differences between the two groups ( p < 0.001). (f) Representative <t>ECG</t> from aCSF (left) and Nore (right). Basal: Both groups show normal sinus rhythm. T wave increase: Both groups had some rats that experienced this. ST elevation: This did not occur in aCSF. Instead normal sinus rhythm at similar timepoint during severe hypoglycemia is shown. Nore shows ST elevation. Third‐degree heart block: Rats from both groups experienced third‐degree heart block. Data are represented as box and whisker plots with median and interquaritle range and min to max values. N = 20–26/group.
Hrv Analysis Software Labchart Pro Version 8, supplied by POWERLAB INC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hrv analysis software labchart pro version 8/product/POWERLAB INC
Average 90 stars, based on 1 article reviews
hrv analysis software labchart pro version 8 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

Image Search Results


Experiment 1: Brain norepinephrine infusion ECG. (a) Mortality during severe hypoglycemia was 16% in aCSF (white bar) and 35% in Nore (black bar) but this was not statistically different. (b) Third‐degree heart block was increased in Nore compared to aCSF. (c) ST elevation was increased in Nore whereas aCSF did not experience ST elevation. (d) Heart rate decreased in both groups during severe hypoglycemia (SH) compared to their respective basals ( p < 0.001). During severe hypoglycemia, Nore had a slight but significantly higher heart rate compared to aCSF ( p < 0.02). (e) QTc prolongation occurred in both groups during severe hypoglycemia compared to basal with no differences between the two groups ( p < 0.001). (f) Representative ECG from aCSF (left) and Nore (right). Basal: Both groups show normal sinus rhythm. T wave increase: Both groups had some rats that experienced this. ST elevation: This did not occur in aCSF. Instead normal sinus rhythm at similar timepoint during severe hypoglycemia is shown. Nore shows ST elevation. Third‐degree heart block: Rats from both groups experienced third‐degree heart block. Data are represented as box and whisker plots with median and interquaritle range and min to max values. N = 20–26/group.

Journal: Physiological Reports

Article Title: Norepinephrine mediates heart block during severe hypoglycemia in male rats

doi: 10.14814/phy2.70010

Figure Lengend Snippet: Experiment 1: Brain norepinephrine infusion ECG. (a) Mortality during severe hypoglycemia was 16% in aCSF (white bar) and 35% in Nore (black bar) but this was not statistically different. (b) Third‐degree heart block was increased in Nore compared to aCSF. (c) ST elevation was increased in Nore whereas aCSF did not experience ST elevation. (d) Heart rate decreased in both groups during severe hypoglycemia (SH) compared to their respective basals ( p < 0.001). During severe hypoglycemia, Nore had a slight but significantly higher heart rate compared to aCSF ( p < 0.02). (e) QTc prolongation occurred in both groups during severe hypoglycemia compared to basal with no differences between the two groups ( p < 0.001). (f) Representative ECG from aCSF (left) and Nore (right). Basal: Both groups show normal sinus rhythm. T wave increase: Both groups had some rats that experienced this. ST elevation: This did not occur in aCSF. Instead normal sinus rhythm at similar timepoint during severe hypoglycemia is shown. Nore shows ST elevation. Third‐degree heart block: Rats from both groups experienced third‐degree heart block. Data are represented as box and whisker plots with median and interquaritle range and min to max values. N = 20–26/group.

Article Snippet: An electrocardiogram (ECG) (PowerLab 26 T; LabChart; ADInstruments, Colorado Springs, CO) was recorded throughout the clamp.

Techniques: Blocking Assay, Whisker Assay

Experiment 2: Blockade of norepinephrine with reserpine ECG. (a) Mortality was completely prevented with Reserpine compared to 13.8% in Control (white bar) but this missed significance. (b) Second‐degree heart block was nearly prevented with Reserpine compared to Control. (c) Third‐degree heart block was prevented with Reserpine compared to 24% in Control. (d) T wave increase occurred in Control but was prevented with Reserpine. (e) Heart rate decreased during severe hypoglycemia compared to basal ( p < 0.001) but to a similar extent in both groups. (f) QTc prolongation occurred in both groups compared to basal ( p < 0.001) but to a lesser extent in Reserpine ( p < 0.02). (g) Representative ECG from Control (left) and Reserpine (right) groups. Basal: Rats from both groups were in normal sinus rhythm. Shown under the control group is T wave increase, ST elevation, and third degree heart block. The rats in the Reserpine group did not have T wave increase, ST elevation, or third Degree heart block. Instead, an ECG at a similar timepoint during severe hypoglycemia (i.e., 1, 2, and 3 h) are shown with the rats in normal sinus rhythm. Data are represented as box and whisker plots with median and interquaritle range and min to max values. N = 20–29/group.

Journal: Physiological Reports

Article Title: Norepinephrine mediates heart block during severe hypoglycemia in male rats

doi: 10.14814/phy2.70010

Figure Lengend Snippet: Experiment 2: Blockade of norepinephrine with reserpine ECG. (a) Mortality was completely prevented with Reserpine compared to 13.8% in Control (white bar) but this missed significance. (b) Second‐degree heart block was nearly prevented with Reserpine compared to Control. (c) Third‐degree heart block was prevented with Reserpine compared to 24% in Control. (d) T wave increase occurred in Control but was prevented with Reserpine. (e) Heart rate decreased during severe hypoglycemia compared to basal ( p < 0.001) but to a similar extent in both groups. (f) QTc prolongation occurred in both groups compared to basal ( p < 0.001) but to a lesser extent in Reserpine ( p < 0.02). (g) Representative ECG from Control (left) and Reserpine (right) groups. Basal: Rats from both groups were in normal sinus rhythm. Shown under the control group is T wave increase, ST elevation, and third degree heart block. The rats in the Reserpine group did not have T wave increase, ST elevation, or third Degree heart block. Instead, an ECG at a similar timepoint during severe hypoglycemia (i.e., 1, 2, and 3 h) are shown with the rats in normal sinus rhythm. Data are represented as box and whisker plots with median and interquaritle range and min to max values. N = 20–29/group.

Article Snippet: An electrocardiogram (ECG) (PowerLab 26 T; LabChart; ADInstruments, Colorado Springs, CO) was recorded throughout the clamp.

Techniques: Control, Blocking Assay, Whisker Assay